DOLTHERA GMBH

dolthera-gmbh-logo

Dolthera GmbH is a biopharmaceutical company that is developing an innovative class of nucleic-acid-based anti-inflammatory drugs. These drugs, based on oligonucleotides that act as decoys for disease-related transcription factors are all directed against biologically validated targets in major chronic diseases with high unmet medical need. With this business concept and the underlying patent-protected technologies, AVONTEC won in 2003 the prestigious German Founders Award that is backed by Mc... Kinsey & Company. Initially, the Company has chosen to focus its patented technology on chronic inflammatory respiratory system and skin diseases. AVONTEC currently has five programs in respiratory disease, skin disease, transplant rejection, cardiovascular disease and autoimmune disease under development. All these indications represent areas with high unmet medical need and strong commercial potential.

#SimilarOrganizations #Financial #Website #More

DOLTHERA GMBH

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2001-01-01

Address:
Martinsried, Bayern, Germany

Country:
Germany

Website Url:
http://www.avontec.com

Status:
Active

Contact:
+498985651600

Email Addresses:
[email protected]

Total Funding:
15.07 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Euro


Similar Organizations

novavax-logo

Novavax

Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.

okairos-logo

Okairos

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

Investors List

german-federal-ministry-of-education-and-research-bmbf_image

German Federal Ministry of Education and Research (BMBF)

German Federal Ministry of Education and Research (BMBF) investment in Grant - Dolthera GmbH

deutsche-venture-capital_image

Deutsche Venture Capital

Deutsche Venture Capital investment in Series B - Dolthera GmbH

innovations-kapital_image

Innovations Kapital

Innovations Kapital investment in Series B - Dolthera GmbH

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series B - Dolthera GmbH

anges-inc_image

AnGes

AnGes investment in Series B - Dolthera GmbH

Official Site Inspections

http://www.avontec.com Semrush global rank: 9.72 M Semrush visits lastest month: 114

  • Host name: hermes.protondns.net
  • IP address: 162.55.25.226
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Dolthera GmbH" on Search Engine